Should I Get The Meningitis B Vaccine

Should I Get The Meningitis B Vaccine – A new study shows that college students are more likely than others to develop a rare, but potentially fatal, bacterial infection.

College students aged 18 to 24 are three and a half times more likely than non-college children to contract meningococcus B, which can cause a fatal blood infection, according to a report released Monday in in Pediatrics. Although a vaccine against MenB is available, few teenagers and young adults receive it, as it is not currently one of the vaccines recommended for all college-going teenagers.

Should I Get The Meningitis B Vaccine

“Although the incidence of Menbi is low, it is a serious disease and parents should be aware that there is a vaccine available and something they can discuss with their child’s doctor about vaccination. This is true,” he said. The first author of the study, pediatrician Dr. Sarah Mbaye, medical officer at the Centers for Disease Control and Prevention.

Emergency Meningitis Vaccine Will Be Imported To Halt Ivy League Outbreak

Vaccines for four other meningococcus strains (MenACWY) have been recommended by the Advisory Committee on Immunization Practices (ACIP) for all adolescents, a group of medical and public health experts. which develops vaccine recommendations.

Currently, ACIP does not recommend MenB for all teens, which is why Mbaeyi recommends that parents and teens — especially those with college plans — talk to his doctor about the risks and benefits of the MenB vaccine.

The main drawback is the cost of the vaccine, experts say, which can go between $300 and $400 for a series of two shots.

Although rare, outbreaks of Menbi have occurred recently. In September, San Diego State University officials reported three students — the number that meet the CDC’s outbreak definition — had developed the disease. And in late 2017, the outbreak began in a consortium of five universities in Massachusetts, and two cases were reported in the fall of that year at the University of Massachusetts, Amherst, and a third case in March 2018 at nearby Smith College.

Provider Survey — Meningitis B Action Project

No one knows for sure why college kids are more likely to develop MenB than others, but it is suspected that they are at increased risk because they live in crowded housing and are in constant contact with others. many other people, said Mbaeyi.

“The bacteria lives in the back of the throat,” Mbaeyi explained, adding that about 10 percent of people carry it without getting sick. “When people are in close contact, they can pass it on to one another.”

Mbaeyi and his colleagues analyzed three years of meningococcal infections collected by the National Notifiable Disease Surveillance System between 2014 and 2016, focusing on cases among people aged 18 to 24.

They found six outbreaks of MenB on college campuses during those years, accounting for about 32 percent of the total cases among college students—the the rest are isolated cases.

Meningitis (meningococcal) Vaccines: What To Know

When comparing the infection rate between university students and non-students, the researchers determined that university students are 3.54 times more likely than others.

The president of the Perelman School of Infectious Diseases, Dr. “If this paper does nothing but start a debate between doctors and students and their parents, I think it has done its job,” said Ebbing Lautenbach. Medicine at the University of Pennsylvania. “Even if there is no comprehensive recommendation from ACIP, at least people can think about it so they can make an informed decision.”

“It’s a rare disease, but if you get it, it can be devastating,” Lautenbach said. “There’s a high mortality rate and if you survive, there’s a lot of long-term consequences.”

Dr. Ira Leeds hopes the new paper will do just that instead of pushing officials to mandate the MenB vaccine for all students entering college.

What Is Meningitis B

Given the prevalence of the disease, it is difficult to justify spending $300 to $400 for every young person going to college, said Leeds, a researcher at the Johns Hopkins Bloomberg School of Public Health. Leeds was the first author of a recently published paper that said vaccinating college students would be ineffective.

Professor of Pediatrics at the University of Pittsburgh Medical Center and Pediatrician at Children’s Hospital of UPMC in Pittsburgh, Dr. Marian Michaels said that in the end, the value of the new paper is to educate doctors and parents.

“When you look at the survey, you see that only 50 percent of pediatricians know about the MenB vaccine and a small percentage – a third – of family medicine doctors know about it, ” he said.

“As far as I’m concerned, it’s a very safe vaccine and while there are no serious cases of meningococcal B disease, when it hits, it hits hard and [quickly],” Michaels said. “Within hours a person can be in the intensive care unit fighting for their life.”

Israel Approves 4th Covid 19 Vaccine Shot For Over 60s

Linda Carroll is a regular health contributor for NBC News and Reuters Health. He is the co-author of “The Concussion Crisis: Anatomy of a Silent Epidemic” and “Out of the Clouds: The Unlikely Horseman and the Unwanted Colt who Became Kings of Kings.” Bacterial meningitis is a serious infection that can lead to months of hospitalization and rehabilitation – and that’s for people who recover. Not everyone who gets bacterial meningitis is lucky. Fortunately, there are meningococcal B vaccines such as Bexsero that can help prevent this dangerous disease.

Meningococcal disease, caused by the bacteria Neisseria meningitidis, is a rare but serious disease. There are at least 12 types, or serogroups, of meningitis. Serogroups A, B, C, W, X, and Y are the main causes of the disease.

Meningococcal serogroup B can cause serogroup B disease, also called meningitis B. Meningitis B causes meningitis (infection and inflammation of the cells that cover the brain and spinal cord) or blood disease. Both types of symptoms can be life-long or even life-threatening.

These symptoms may not be seen in children. The child, on the other hand, may be lazy or inactive, irritable, vomiting, or not eating.

How A Molecule Gets To The Masses

Bacterial meningococcal disease can be treated with antibiotics, but even with treatment, one or two out of 10 infected people die.

Seek medical attention immediately if you experience the meningococcal symptoms described above. Often the symptoms are similar to the flu, so it is better to be careful and monitor. The best way to prevent disease is vaccination.

Bexsero is a non-live, injectable vaccine that helps prevent meningococcal disease caused by serogroup B. Although Bexsero does not protect against meningococcal type B disease, Bexsero is 66% up to 91% effective in treating meningitis. B thread.

YES There are two types of meningitis vaccine. It protects against various types of meningococcal disease.

Boots Launches Meningitis B Vaccine So Parents Can Protect Their Kids From The Deadly Disease At Home

Bexsero is approved for anyone between the ages of 10 and 25. However, the Centers for Disease Control and Prevention (CDC) recommends the group B meningococcal vaccine (Baxero and Trumemba) for adolescents and young adults ages 16 to 25, and people feet that may be infected.

The CDC also recommends the MenB vaccine for adults working as microbiologists who have been exposed to Neisseria meningitidis.

People who are allergic to any of the ingredients in Bexasero or who have had a severe reaction to Bexasero in the past should not receive the vaccine. Women who are pregnant or breastfeeding should discuss vaccinations with their nurses. Animal studies show that Bexsero is safe during pregnancy, but there is not enough information to say that it is safe for use in pregnancy. It is recommended that Bexsero vaccine be given to expectant mothers only when absolutely necessary, for example, if the mother is at high risk.

The caps used on pre-filled syringes contain natural rubber latex, which can cause side effects in sensitive people.

Biontech Warns ‘no Data’ To Support Uk Plan To Space Out Covid Shots

People who are moderately or severely ill should wait until they are well to receive the vaccine.

Bexsero can be safely given to immunocompromised people, but the immune system may have a weak response or reduced immunity, which may reduce its effectiveness.

Bexsero is administered by injection – injected into a muscle using a syringe. According to US Food and Drug Administration (FDA) guidelines, two doses of 0.5 ml are required for maximum protection. The dose should be given for at least one month.

It is best to take the second dose on schedule, ie as soon as one month after the first dose. A second dose of vaccine is still effective when more than a month has passed since the previous dose of Bexsero. However, the effectiveness of the first dose decreases over time, so getting a second dose on time helps you get full protection, sooner.

Government Rejects Calls For Meningitis B Vaccine For All Children

The CDC states that the MenB vaccine can be given at the same time as the Tdap, HPV, and MenACWY vaccines. If given during the same visit, the injection should be done at a different injection site and with a different syringe.

Bexsero should not be used interchangeably with other MenB vaccines to complete the vaccination series. the

Should i get meningitis b vaccine, who should get a meningitis vaccine, how often should i get meningitis vaccine, should i get the meningitis vaccine, when should you get a meningitis vaccine, should i get meningitis vaccine, who should get meningitis b vaccine, who should get meningitis vaccine, should i get the meningitis b vaccine, how often should you get meningitis vaccine, which meningitis vaccine should i get, should adults get meningitis vaccine